CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading
Antibodies: The Building Blocks of Cures

Antibodies: The Building Blocks of Cures

John Armstrong, Head of Research; Head of BD; Global Strategic Programs; Global Straegic Marketing, Galderma

The Future of Life Sciences Industry

The Future of Life Sciences Industry

Matthew (Matt) Hewitt, Executive Director, Scientific Solutions C and GT, Charles River

Accelerating Digital Transformation through an Agile, Customer-centric Approach

Accelerating Digital Transformation through an Agile, Customer-centric Approach

Mark Mintz, Chief Information Officer at Charles River Laboratories

Re-imagining Learning in a Post-Pandemic World

Re-imagining Learning in a Post-Pandemic World

Sebastian Teo, Head of Learning & Talent Management, Linde

How Charles River Labs is Re-Imaging Digital Transformation with Design Thinking

How Charles River Labs is Re-Imaging Digital Transformation with Design Thinking

Erin Howard, Executive Director of Product, Service, and Experience Design, Charles River Labs

How can Manufacturing Companies Keep Pace with the Shifting Trends of Oncology Drug Development

How can Manufacturing Companies Keep Pace with the Shifting Trends of Oncology Drug Development

Li Chen, Vp & General Manager, West Pharmaceutical

The Science Behind Addiction and Why it Matters to Employers

The Science Behind Addiction and Why it Matters to Employers

Justin Yang, M.D. MPH, Medical Director, Quit Genius

Previous Next
  • Antibodies: The Building Blocks of Cures

    Antibodies: The Building Blocks of Cures

    John Armstrong, Head of Research; Head of BD; Global Strategic Programs; Global Straegic Marketing, Galderma
  • The Future of Life Sciences Industry

    The Future of Life Sciences Industry

    Matthew (Matt) Hewitt, Executive Director, Scientific Solutions C and GT, Charles River
  • Accelerating Digital Transformation through an Agile, Customer-centric Approach

    Accelerating Digital Transformation through an Agile, Customer-centric Approach

    Mark Mintz, Chief Information Officer at Charles River Laboratories
  • Re-imagining Learning in a Post-Pandemic World

    Re-imagining Learning in a Post-Pandemic World

    Sebastian Teo, Head of Learning & Talent Management, Linde
  • How Charles River Labs is Re-Imaging Digital Transformation with Design Thinking

    How Charles River Labs is Re-Imaging Digital Transformation with Design Thinking

    Erin Howard, Executive Director of Product, Service, and Experience Design, Charles River Labs
  • How can Manufacturing Companies Keep Pace with the Shifting Trends of Oncology Drug Development

    How can Manufacturing Companies Keep Pace with the Shifting Trends of Oncology Drug Development

    Li Chen, Vp & General Manager, West Pharmaceutical
  • The Science Behind Addiction and Why it Matters to Employers

    The Science Behind Addiction and Why it Matters to Employers

    Justin Yang, M.D. MPH, Medical Director, Quit Genius

Put your Frontline Teams in the Driving Seat through a Personalized, Customer-Centric Approach

Cloud Computing for Affordable Medicines

Manoj Shah, VP, IT and Business Support, Amneal Pharmaceuticals (NYSE: AMRX)

Molecular Devices Challenges and Trends in the Sythetic Biology Space

Dan O’Connor, VP Drug Discovery, Western Markets, Molecular Devices

Science-Led Data Collection: Because a Clinical Trial is Only as Good as Its Data

Lindsay Hughes, PhD, MS – Director, eCOA Science & Consulting and Jowita Marszewska, PhD – eCOA Scientific Advisor at Clario

Accelerating Early-Stage Drug Development

Safwan Kezbor, M.D. Medical Director, Clinical Development, Shionogi Inc.

Medical Affairs Takes Centre Stage

Dr Sarah Tregenza PhD BSc(Hons), APAC Oncology Medical Affairs Director, Pierre Fabre

The Role Of Patient Reported Outcomes To Support Reimbursement And Market Access In Major European Countries And The Us

Lothar Tremmel, Vice President, QCSR at CSL Behring

Accelerating Drug Development Of Novel Targeted Therapies Through Histology-Agnostic Oncology Clinical Trials

Hua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker at Zai Lab

Growing Demand For More Specialized Services Specialized Services: A New Paradigm In Therapeutics

Brian Fry, Director, Global Cell Therapy, Charles River Laboratories

Could A Syndromic Diagnosis Overcome Challenges Faced By Antimicrobial Stewardship Programs During The Covid-19 Pandemic?

Sonia N. Rao, PharmD, BCIDP and Davide Manissero, MD, MRCPCH, MSc, DTM&H, QIAGEN

Immunotherapy: shaping a new era of patient centric care

Danie du Plessis, Executive VP Medical Affairs, Kyowa Kirin

The Cancer Immunotherapy Treatment Paradigm

Charles Drake, M.D., Ph.D., Vice President, Immuno-Oncology, Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson

Understanding the Importance of Building Rapport to Enhance Patient Experience in Telehealth

Toufic Kachaamy, Medical Director of Gastroenterology, Cancer Treatment Centers of America

Leveraging Technology to Boost Immunotherapy

Li Chen, Vice President & General Manager, Biologics, West Pharmaceutical Services, Inc.

The World of Omnichannel Comes to Life Sciences: What Digital Transformation Looks Like in the Pharma Industry

Paul R. Whitacre, PMP, Associate Director, Digital Excellence, Commercial Strategy & Operations Astellas Pharma US, Inc.

The World of Omnichannel Comes to Life Sciences: What Digital Transformation Looks Like in the Pharma Industry

Paul R. Whitacre, PMP, Associate Director, Digital Excellence, Commercial Strategy & Operations Astellas Pharma US, Inc.

Successful Digital Transformation

Shubha Chaudhari, Head of GSK Clinical Technology Solutions

Innovation Vs Validation in Early Drug Discovery

Carlos Pedraza, PhD. Director of CNS Biology at Alkermes

A proposal for a new strategy in oncology clinical development

Stefano Ferrara, Director, Clinical Science, BeiGene
Loading...

Thank you for Subscribing to Life Science Review Weekly Brief

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/contributors/